Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Ola Vedin

Boehringer Ingelheim, Binger Str. 173, 
Ingelheim Am Rhein, RP, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Boehringer Ingelheim, Binger Str. 173, 
Ingelheim Am Rhein, RP, DE 
OverviewLocationsClinical Research

Overview

Ola Vedin practices in Ingelheim Am Rhein, Germany. Ms. Vedin is rated as an Advanced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure, Cardiac Amyloidosis, Coronary Heart Disease, and Heart Failure with Preserved Ejection Fraction (HFpEF).

Her clinical research consists of co-authoring 41 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles and participated in 1 clinical trial in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Female

Locations

Boehringer Ingelheim, Binger Str. 173, Ingelheim Am Rhein, RP 55216, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction, SPIRRIT-HFPEF
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction, SPIRRIT-HFPEF
Enrollment Status: Recruiting
Publish Date: October 22, 2024
Intervention Type: Other, Drug
Study Drug: Spironolactone
Study Phase: Phase 3
A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload
A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload
Enrollment Status: Terminated
Publish Date: August 05, 2021
Intervention Type: Device
PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure
PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure
Enrollment Status: Terminated
Publish Date: May 05, 2021
Intervention Type: Other, Device
Study Phase: Not Applicable
View 2 Less Clinical Trial

41 Total Publications

Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.
Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Journal of the American Society of Nephrology : JASN
Published: July 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Vedin's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile